IN8bio Inc. (INAB)
0.30
-0.02 (-5.21%)
At close: Jan 15, 2025, 3:59 PM
0.30
0.20%
After-hours Jan 15, 2025, 04:03 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost of Revenue | 2.50M | 1.10M | 251.00K | 96.00K | 96.00K | 96.00K |
| Gross Profit | -2.50M | -1.10M | -251.00K | -96.00K | -96.00K | -96.00K |
| Operating Income | -30.34M | -28.52M | -14.65M | -8.56M | -5.13M | -2.00M |
| Interest Income | n/a | n/a | n/a | n/a | n/a | n/a |
| Pretax Income | -30.01M | -28.52M | -14.65M | -8.56M | -5.13M | -2.08M |
| Net Income | -30.01M | -27.42M | -14.65M | -8.56M | -5.13M | -2.08M |
| Selling & General & Admin | 13.51M | 14.46M | 7.31M | 3.18M | 2.71M | 1.42M |
| Research & Development | 16.83M | 14.06M | 7.35M | 5.38M | 2.36M | 581.00K |
| Other Expenses | n/a | n/a | n/a | n/a | n/a | -63.00K |
| Operating Expenses | 30.34M | 28.52M | 14.65M | 8.56M | 5.07M | 2.00M |
| Interest Expense | n/a | n/a | n/a | n/a | n/a | 14.00K |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 30.34M | 28.52M | 14.65M | 8.56M | 5.07M | 2.00M |
| Income Tax | n/a | -1.10M | 551.44K | -118.30K | -68.00K | -63.00K |
| Shares Outstanding (Basic) | 29.86M | 20.97M | 18.78M | 19.35M | 19.35M | 6.17M |
| Shares Outstanding (Diluted) | 29.86M | 20.97M | 18.78M | 19.35M | 19.35M | 6.17M |
| EPS (Basic) | -1 | -1.31 | -0.78 | -0.44 | -0.27 | -0.34 |
| EPS (Diluted) | -1 | -1.31 | -0.78 | -0.44 | -0.27 | -0.34 |
| EBITDA | -28.50M | -27.42M | -14.40M | -8.47M | -5.04M | -1.97M |
| Depreciation & Amortization | 1.83M | 1.10M | 251.00K | 96.00K | 96.00K | 96.00K |